S'abonner

Pneumothorax in critically ill patients with COVID-19 infection: Incidence, clinical characteristics and outcomes in a case control multicenter study - 11/06/21

Doi : 10.1016/j.rmed.2021.106464 
Amit Chopra a, , Ali Hani Al-Tarbsheh b, 1, Nidhi J. Shah c, 1, Hamid Yaqoob d, 1, Kurt Hu f, 1, Paul J. Feustel g, Ronaldo Ortiz-Pacheco c, e, Kinner M. Patel c, e, Jozef Oweis b, Natalya Kozlova d, Spyridon Zouridis b, Sahar Ahmad c, e, Oleg Epelbaum d, Woon H. Chong a, John T. Huggins h, Biplab K. Saha i, Edward Conuel b, Hau Chieng b, Jeannette Mullins a, Divyansh Bajaj f, Boris Shkolnik a, Rachel Vancavage a , Nagendra Madisi a, Marc A. Judson a
a Department of Medicine, Pulmonary and Critical Care Medicine, Albany Medical Center, NY, USA 
b Department of Medicine, Albany Medical Center, NY, USA 
c Department of Medicine, Stony Brook Medicine, Stony Brook, NY, USA 
d Division of Pulmonary, Critical Care, and Sleep Medicine, Westchester Medical Center, Valhalla, NY, USA 
e Division of Pulmonary, Critical Care and Sleep Medicine, Stony Brook Medicine, NY, USA 
f Division of Pulmonary, Critical Care and Medicine, Medical College of Wisconsin, Milwaukee, WI, USA 
g Department of Neuroscience and Experimental Therapeutics, Albany Medical Center, NY, USA 
h Department of Medicine, Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Medical University of South Carolina, Charleston, SC, USA 
i Division of Pulmonary and Critical Care Medicine, Ozarks Medical Center, West Plains, MO, USA 

Corresponding author. Division of Pulmonary and Critical Care Medicine Department of Medicine, MC- 91 Albany Medical Center, Albany, NY, 12208, USA.Division of Pulmonary and Critical Care Medicine Department of MedicineMC- 91 Albany Medical CenterAlbanyNY12208USA

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Background

The clinical features and outcomes of mechanically ventilated patients with COVID-19 infection who develop a pneumothorax has not been rigorously described or compared to those who do not develop a pneumothorax.

Purpose

To determine the incidence, clinical characteristics, and outcomes of critically ill patients with COVID-19 infection who developed pneumothorax. In addition, we compared the clinical characteristics and outcomes of mechanically ventilated patients who developed a pneumothorax with those who did not develop a pneumothorax.

Methods

This study was a multicenter retrospective analysis of all adult critically ill patients with COVID-19 infection who were admitted to intensive care units in 4 tertiary care centers in the United States.

Results

A total of 842 critically ill patients with COVID-19 infection were analyzed, out of which 594 (71%) were mechanically ventilated. The overall incidence of pneumothorax was 85/842 (10%), and 80/594 (13%) in those who were mechanically ventilated. As compared to mechanically ventilated patients in the non-pneumothorax group, mechanically ventilated patients in the pneumothorax group had worse respiratory parameters at the time of intubation (mean PaO2:FiO2 ratio 105 vs 150, P<0.001 and static respiratory system compliance: 30ml/cmH2O vs 39ml/cmH2O, P = 0.01) and significantly higher in-hospital mortality (63% vs 49%, P = 0.04).

Conclusion

The overall incidence of pneumothorax in mechanically ventilated patients with COVID-19 infection was 13%. Mechanically ventilated patients with COVID-19 infection who developed pneumothorax had worse gas exchange and respiratory mechanics at the time of intubation and had a higher mortality compared to those who did not develop pneumothorax.

Le texte complet de cet article est disponible en PDF.

Highlights

The incidence of pneumothorax was 10% in critically ill and 13% in mechanically ventilated patients with COVID-19 infection.
Patients who developed a pneumothorax had greater severity of lung disease as compared to those without pneumothorax.
Odds of in-hospital death were increased nearly two-fold in those who had a pneumothorax as compared to those without pneumothorax.

Le texte complet de cet article est disponible en PDF.

Keywords : Pneumothorax, Pneumomediastinum, Barotrauma, 2, SARS-CoV-2, Coronavirus disease 2019, COVID-19, Incidence, Mortality


Plan


© 2021  Elsevier Ltd. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 184

Article 106464- août 2021 Retour au numéro
Article précédent Article précédent
  • Effectiveness of the manual diaphragmatic stretching technique on respiratory function in cerebral palsy: A randomised controlled trial
  • Surussawadi Bennett, Wantana Siritaratiwat, Nittaya Tanrangka, Michael John Bennett, Jaturat Kanpittaya
| Article suivant Article suivant
  • Safety and efficacy of omadacycline by body mass index in patients with community-acquired bacterial pneumonia: Subanalysis from a randomized controlled trial
  • Manjunath P. Pai, Mark Wilcox, Surya Chitra, Paul McGovern

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.